▶ 調査レポート

臨床栄養の世界市場:投与経路別(経口、経腸、非経口)、疾病タイプ別(がん、消化器(胃腸)疾患、神経疾患、腎疾患、呼吸器疾患、メタボリックシンドローム、その他)、エンドユーザー別、地域別分析

• 英文タイトル:Global Clinical Nutrition Market - Segmented by Route of Administration, Disease, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。臨床栄養の世界市場:投与経路別(経口、経腸、非経口)、疾病タイプ別(がん、消化器(胃腸)疾患、神経疾患、腎疾患、呼吸器疾患、メタボリックシンドローム、その他)、エンドユーザー別、地域別分析 / Global Clinical Nutrition Market - Segmented by Route of Administration, Disease, End-Users and Geography - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040937資料のイメージです。• レポートコード:B-MOR-040937
• 出版社/出版日:Mordor Intelligence / 2018年2月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Single User(1名様用)¥463,250 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥490,500 (USD4,500)▷ お問い合わせ
  Corporate User¥953,750 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、臨床栄養の世界市場について調べ、臨床栄養の世界規模、市場動向、市場環境、投与経路別(経口、経腸、非経口)分析、疾病タイプ別(がん、消化器(胃腸)疾患、神経疾患、腎疾患、呼吸器疾患、メタボリックシンドローム、その他)分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・臨床栄養の世界市場インサイト
・臨床栄養の世界市場環境
・臨床栄養の世界市場動向
・臨床栄養の世界市場規模
・臨床栄養の世界市場規模:投与経路別(経口、経腸、非経口)
・臨床栄養の世界市場規模:疾病タイプ別(がん、消化器(胃腸)疾患、神経疾患、腎疾患、呼吸器疾患、メタボリックシンドローム、その他)
・臨床栄養の世界市場規模:エンドユーザー別
・臨床栄養の世界市場:地域別市場規模・分析
・臨床栄養の北米市場規模・予測
・臨床栄養のアメリカ市場規模・予測
・臨床栄養のヨーロッパ市場規模・予測
・臨床栄養のアジア市場規模・予測
・臨床栄養の日本市場規模・予測
・臨床栄養の中国市場規模・予測
・臨床栄養のインド市場規模・予測
・臨床栄養の韓国市場規模・予測
・関連企業情報・競争状況

The global clinical nutrition market has been estimated at USD 44,554 million in 2017. The market is expected to register a CAGR of 5.8% during the forecast period, 2018 to 2023. Asia-pacific accounted for the largest market, while North America is the next to Asia-Pacific in the clinical nutrition market.

High Spending on Healthcare

Healthcare spending continues to grow faster than economic growth in most countries, maintaining a trend observed over decades. The presence of equitable, responsive, and efficient health systems across the countries of North America, Europe, United Kingdom, and Asia-Pacific has also contributed to the maximum share of GDP for healthcare expenditure. The United States Government spends the largest in healthcare. In 2014, the United States spent nearly USD 3 trillion on healthcare, with advanced healthcare facilities, high cost of treatments and high healthcare awareness being the major reasons. As the healthcare spending increases worldwide among major countries of the world, along with the prevalence of metabolic disorders, rising aging population and rise of middle class in the emerging economies are driving the clinical nutrition market.

Due to Lack of Awareness

Marketing of clinical nutrition products is one major hurdle for the growth of the clinical nutrition market. The general perception about clinical nutrition poses a big challenge in communicating the nutritional products developed to treat or prevent diseases like diabetes, Alzheimer’s and obesity, among others, as people perceive that nutritional products are only for malnourished people and not for prevention or treatment of diseases. Marketing for these disease-specific nutritional products is challenging for the marketers in the clinical nutrition market. Along with the factors such as lack of awareness among the people and the nature of government coverage/reimbursement across countries are restraining the market.

Asia-Pacific to Dominate the Market Growth

Asia-Pacific is the largest geographical market, which is currently valued at USD 18,614 million in 2017 and is also expected to grow at a highest CAGR of 6.94%. China is the largest market segment of the Asia-Pacific region, valued at USD 7,290 million in the year 2017. However, India is the fastest growing segment of this region. And North America region is the next to the Asia-Pacific region.

Key Developments in the Market

• January 2018: French dairy firm Lactalis has to recall millions of powdered milk products off the shelf after a salmonella scare at a French diary firm. This is expected to create opportunities for new entrants in the clinical nutrition market.
• January 2018: Fresenius Kabi and ASPEN (The American Society for Parenteral and Enteral Nutrition) are creating awareness among clinicians who provide nutrition support
by launching video series that highlights the best practices for dosing, preparing and administering intravenous lipid emulsions (ILE).

Key Players: ABBOTT NUTRITION, NESTLE HEALTH SCIENCE, BAXTER HEALTHCARE, B. BRAUN MELSUNGEN AG, NUTRICIA, MEAD JOHNSON, PERRIGO COMPANY PLC, FRESENIUS KABI

Reasons to Purchase this Report

• Current and future clinical nutrition market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
3 months analyst support along with the Market Estimate sheet in excel.

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

レポート目次

1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING PREVALENCE OF METABOLIC DISORDERS
6.1.2 HIGH SPENDING ON HEALTHCARE
6.1.3 RISE OF MIDDLE-CLASS IN EMERGING ECONOMIES
6.2 MARKET RESTRAINTS
6.2.1 UNWILLINGNESS OF HOSPITALS AND IN-HOUSE PHARMACIES/DISPENCARIES TO MAINTAIN THE REQUIRED STOCK OF CLINICAL NUTRITION PRODUCTS
6.2.2 HETEROGENOUS NATURE OF GOVERNMENT COVERAGE/REIMBURSEMENT ACROSS COUNTRIES
6.2.3 IMPRECISE PERCEPTION ABOUT CLINICAL NUTRITION
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 SEGMENTATION-BY ROUTE OF ADMINISTRATION
7.1.1 ORAL
7.1.2 ENTERAL
7.1.3 PARENTERAL
7.2 SEGMENTATION-BY DISEASE TYPE
7.2.1 NUTRITIONAL SUPPORT IN CANCER
7.2.2 NUTRITIONAL SUPPORT IN GASTROINTESTINAL (GI) DISEASES
7.2.3 NUTRITIONAL SUPPORT IN NEUROLOGICAL DISEASES
7.2.4 NUTRITIONAL SUPPORT IN RENAL DISEASES
7.2.5 NUTRITIONAL SUPPORT IN RESPIRATORY DISEASES
7.2.6 NUTRITIONAL SUPPORT IN METABOLIC SYNDROMES
7.2.7 NUTRITIONAL SUPPORT IN OTHER DISEASE AREAS
7.3 SEGMENTATION-BY END USER
7.3.1 INFANT
7.3.2 CHILD
7.3.3 ADULT
7.3.4 GERIATRIC
7.4 SEGMENTATION-BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 UNITED STATES
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 GERMANY
7.4.2.3 UNITED KINGDOM
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 CHINA
7.4.3.2 JAPAN
7.4.3.3 INDIA
7.4.3.4 AUSTRALIA & NEW ZEALAND
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF ASIA-PACIFIC
7.4.4 MIDDLE EAST & AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF THE MIDDLE EAST & AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 ABBOTT NUTRITION
9.2 NESTLE HEALTH SCIENCE
9.3 BAXTER HEALTHCARE
9.4 B. BRAUN MELSUNGEN AG
9.5 NUTRICIA
9.6 MEAD JOHNSON
9.7 PERRIGO COMPANY PLC
9.8 FRESENIUS KABI
10. FUTURE OF THE MARKET